{
    "id": 3165,
    "fullName": "AKT1 Q79K",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "AKT1 Q79K lies within the PH domain of the Akt1 protein (UniProt.org). Q79K results in increased Akt1 kinase activity, downstream signaling (PMID: 27232857), and is transforming in cell culture (PMID: 23134728, PMID: 23237847).",
            "references": [
                {
                    "id": 1909,
                    "pubMedId": 23237847,
                    "title": "Functional analysis of non-hotspot AKT1 mutants found in human breast cancers identifies novel driver mutations: implications for personalized medicine.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23237847"
                },
                {
                    "id": 11970,
                    "pubMedId": 27232857,
                    "title": "AKT in cancer: new molecular insights and advances in drug development.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27232857"
                },
                {
                    "id": 103,
                    "pubMedId": 23134728,
                    "title": "Disruption of PH-kinase domain interactions leads to oncogenic activation of AKT in human cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23134728"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 207,
        "geneSymbol": "AKT1",
        "terms": [
            "AKT1",
            "AKT",
            "CWS6",
            "PKB",
            "PKB-ALPHA",
            "PRKBA",
            "RAC",
            "RAC-ALPHA"
        ]
    },
    "variant": "Q79K",
    "createDate": "02/17/2015",
    "updateDate": "08/23/2018",
    "referenceTranscriptCoordinates": {
        "id": 167060,
        "transcript": "NM_001014432",
        "gDna": "chr14:g.104776711G>T",
        "cDna": "c.235C>A",
        "protein": "p.Q79K",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11437,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, an ovarian cancer patient harboring AKT1 Q79K demonstrated tumor regression that lasted 14 months when treated with Capivasertib (AZD5363) (PMID: 28489509; NCT01226316).",
            "molecularProfile": {
                "id": 2989,
                "profileName": "AKT1 Q79K"
            },
            "therapy": {
                "id": 655,
                "therapyName": "Capivasertib",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 9361,
                    "pubMedId": 28489509,
                    "title": "AKT Inhibition in Solid Tumors With AKT1 Mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28489509"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8125,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the combination of MK2206 and Zelboraf (vemurafenib) inhibited AKT activation and growth of PTEN-expressing BRAF V600-mutant melanoma cells expressing AKT1 Q79K in culture, with increased efficacy over either agent alone (PMID: 24265152).",
            "molecularProfile": {
                "id": 26173,
                "profileName": "AKT1 Q79K BRAF V600X PTEN pos"
            },
            "therapy": {
                "id": 4635,
                "therapyName": "MK2206 + Vemurafenib",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6551,
                    "pubMedId": 24265152,
                    "title": "A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24265152"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8106,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, expression of AKT1 Q79K in a wild-type PTEN-expressing BRAF V600-mutant melanoma cell line conferred resistance to Zelboraf (vemurafenib) in culture (PMID: 24265152).",
            "molecularProfile": {
                "id": 26173,
                "profileName": "AKT1 Q79K BRAF V600X PTEN pos"
            },
            "therapy": {
                "id": 342,
                "therapyName": "Vemurafenib",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 6551,
                    "pubMedId": 24265152,
                    "title": "A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24265152"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2989,
            "profileName": "AKT1 Q79K",
            "profileTreatmentApproaches": [
                {
                    "id": 11439,
                    "name": "Akt1 Inhibitor",
                    "profileName": "AKT1 Q79K"
                },
                {
                    "id": 11440,
                    "name": "Akt Inhibitor (Pan)",
                    "profileName": "AKT1 Q79K"
                }
            ]
        },
        {
            "id": 26173,
            "profileName": "AKT1 Q79K BRAF V600X PTEN pos",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 167061,
            "transcript": "XM_005267401",
            "gDna": "chr14:g.104776711G>T",
            "cDna": "c.235C>A",
            "protein": "p.Q79K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 167063,
            "transcript": "XM_017021078",
            "gDna": "chr14:g.104776711G>T",
            "cDna": "c.235C>A",
            "protein": "p.Q79K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 167062,
            "transcript": "NM_005163",
            "gDna": "chr14:g.104776711G>T",
            "cDna": "c.235C>A",
            "protein": "p.Q79K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 167064,
            "transcript": "XM_017021077",
            "gDna": "chr14:g.104776711G>T",
            "cDna": "c.235C>A",
            "protein": "p.Q79K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 167065,
            "transcript": "XM_017021076",
            "gDna": "chr14:g.104776711G>T",
            "cDna": "c.235C>A",
            "protein": "p.Q79K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 167060,
            "transcript": "NM_001014432",
            "gDna": "chr14:g.104776711G>T",
            "cDna": "c.235C>A",
            "protein": "p.Q79K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 167066,
            "transcript": "XM_017021075",
            "gDna": "chr14:g.104776711G>T",
            "cDna": "c.235C>A",
            "protein": "p.Q79K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 167059,
            "transcript": "NM_001014431",
            "gDna": "chr14:g.104776711G>T",
            "cDna": "c.235C>A",
            "protein": "p.Q79K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}